EMEA (Europe, Middle East and Africa) Pancreatic Endocrine Tumor Drug Market Report 2018

January 2018 | 109 pages | ID: E0636016160EN
QYResearch

Abstracts

In this report, the EMEA Pancreatic Endocrine Tumor Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Pancreatic Endocrine Tumor Drug for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Pancreatic Endocrine Tumor Drug market competition by top manufacturers/players, with Pancreatic Endocrine Tumor Drug sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Ipsen S.A.
• Jiangsu Hengrui Medicine Co., Ltd.
• MediaPharma s.r.l.
• Novartis AG
• OXiGENE, Inc.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Buparlisib Hydrochloride
• Dovitinib Lactate
• Fosbretabulin Tromethamine
• Lanreotide Acetate
• MPHE-001B
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Clinic
• Research Center
• Hospital

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Pancreatic Endocrine Tumor Drug Market Report 2018

1 PANCREATIC ENDOCRINE TUMOR DRUG OVERVIEW

1.1 Product Overview and Scope of Pancreatic Endocrine Tumor Drug
1.2 Classification of Pancreatic Endocrine Tumor Drug
  1.2.1 EMEA Pancreatic Endocrine Tumor Drug Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Pancreatic Endocrine Tumor Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Buparlisib Hydrochloride
  1.2.4 Dovitinib Lactate
  1.2.5 Fosbretabulin Tromethamine
  1.2.6 Lanreotide Acetate
  1.2.7 MPHE-001B
  1.2.8 Others
1.3 EMEA Pancreatic Endocrine Tumor Drug Market by Application/End Users
  1.3.1 EMEA Pancreatic Endocrine Tumor Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Clinic
  1.3.3 Research Center
  1.3.4 Hospital
1.4 EMEA Pancreatic Endocrine Tumor Drug Market by Region
  1.4.1 EMEA Pancreatic Endocrine Tumor Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Pancreatic Endocrine Tumor Drug (2013-2025)
  1.5.1 EMEA Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Pancreatic Endocrine Tumor Drug Revenue and Growth Rate (2013-2025)

2 EMEA PANCREATIC ENDOCRINE TUMOR DRUG COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Pancreatic Endocrine Tumor Drug Market Competition by Players/Manufacturers
  2.1.1 EMEA Pancreatic Endocrine Tumor Drug Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Pancreatic Endocrine Tumor Drug Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Pancreatic Endocrine Tumor Drug Sale Price by Players (2013-2018)
2.2 EMEA Pancreatic Endocrine Tumor Drug (Volume and Value) by Type/Product Category
  2.2.1 EMEA Pancreatic Endocrine Tumor Drug Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Pancreatic Endocrine Tumor Drug Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Pancreatic Endocrine Tumor Drug Sale Price by Type (2013-2018)
2.3 EMEA Pancreatic Endocrine Tumor Drug (Volume) by Application
2.4 EMEA Pancreatic Endocrine Tumor Drug (Volume and Value) by Region
  2.4.1 EMEA Pancreatic Endocrine Tumor Drug Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Pancreatic Endocrine Tumor Drug Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Pancreatic Endocrine Tumor Drug Sales Price by Region (2013-2018)

3 EUROPE PANCREATIC ENDOCRINE TUMOR DRUG (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Pancreatic Endocrine Tumor Drug Sales and Value (2013-2018)
  3.1.1 Europe Pancreatic Endocrine Tumor Drug Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Pancreatic Endocrine Tumor Drug Revenue and Growth Rate (2013-2018)
3.2 Europe Pancreatic Endocrine Tumor Drug Sales and Market Share by Type
3.3 Europe Pancreatic Endocrine Tumor Drug Sales and Market Share by Application
3.4 Europe Pancreatic Endocrine Tumor Drug Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Pancreatic Endocrine Tumor Drug Sales Volume by Countries (2013-2018)
  3.4.2 Europe Pancreatic Endocrine Tumor Drug Revenue by Countries (2013-2018)
  3.4.3 Germany Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2013-2018)
  3.4.4 France Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2013-2018)
  3.4.5 UK Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2013-2018)
  3.4.6 Russia Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2013-2018)
  3.4.7 Italy Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2013-2018)

4 MIDDLE EAST PANCREATIC ENDOCRINE TUMOR DRUG (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Pancreatic Endocrine Tumor Drug Sales and Value (2013-2018)
  4.1.1 Middle East Pancreatic Endocrine Tumor Drug Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Pancreatic Endocrine Tumor Drug Revenue and Growth Rate (2013-2018)
4.2 Middle East Pancreatic Endocrine Tumor Drug Sales and Market Share by Type
4.3 Middle East Pancreatic Endocrine Tumor Drug Sales and Market Share by Application
4.4 Middle East Pancreatic Endocrine Tumor Drug Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Pancreatic Endocrine Tumor Drug Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Pancreatic Endocrine Tumor Drug Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2013-2018)
  4.4.4 Israel Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2013-2018)
  4.4.5 UAE Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2013-2018)
  4.4.6 Iran Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2013-2018)

5 AFRICA PANCREATIC ENDOCRINE TUMOR DRUG (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Pancreatic Endocrine Tumor Drug Sales and Value (2013-2018)
  5.1.1 Africa Pancreatic Endocrine Tumor Drug Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Pancreatic Endocrine Tumor Drug Revenue and Growth Rate (2013-2018)
5.2 Africa Pancreatic Endocrine Tumor Drug Sales and Market Share by Type
5.3 Africa Pancreatic Endocrine Tumor Drug Sales and Market Share by Application
5.4 Africa Pancreatic Endocrine Tumor Drug Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Pancreatic Endocrine Tumor Drug Sales Volume by Countries (2013-2018)
  5.4.2 Africa Pancreatic Endocrine Tumor Drug Revenue by Countries (2013-2018)
  5.4.3 South Africa Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Pancreatic Endocrine Tumor Drug Sales and Growth Rate (2013-2018)

6 EMEA PANCREATIC ENDOCRINE TUMOR DRUG MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Ipsen S.A.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pancreatic Endocrine Tumor Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Ipsen S.A. Pancreatic Endocrine Tumor Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Jiangsu Hengrui Medicine Co., Ltd.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Pancreatic Endocrine Tumor Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 MediaPharma s.r.l.
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Pancreatic Endocrine Tumor Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Novartis AG
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Pancreatic Endocrine Tumor Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Novartis AG Pancreatic Endocrine Tumor Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 OXiGENE, Inc.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Pancreatic Endocrine Tumor Drug Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview

7 PANCREATIC ENDOCRINE TUMOR DRUG MANUFACTURING COST ANALYSIS

7.1 Pancreatic Endocrine Tumor Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pancreatic Endocrine Tumor Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pancreatic Endocrine Tumor Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pancreatic Endocrine Tumor Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PANCREATIC ENDOCRINE TUMOR DRUG MARKET FORECAST (2018-2025)

11.1 EMEA Pancreatic Endocrine Tumor Drug Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Pancreatic Endocrine Tumor Drug Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Pancreatic Endocrine Tumor Drug Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Pancreatic Endocrine Tumor Drug Price and Trend Forecast (2018-2025)
11.2 EMEA Pancreatic Endocrine Tumor Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Pancreatic Endocrine Tumor Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Pancreatic Endocrine Tumor Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Pancreatic Endocrine Tumor Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Pancreatic Endocrine Tumor Drug Sales Forecast by Type (2018-2025)
11.7 EMEA Pancreatic Endocrine Tumor Drug Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pancreatic Endocrine Tumor Drug
Figure EMEA Pancreatic Endocrine Tumor Drug Sales Volume (K Pcs) by Type (2013-2025)
Figure EMEA Pancreatic Endocrine Tumor Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Buparlisib Hydrochloride Product Picture
Figure Dovitinib Lactate Product Picture
Figure Fosbretabulin Tromethamine Product Picture
Figure Lanreotide Acetate Product Picture
Figure MPHE-001B Product Picture
Figure Others Product Picture
Figure EMEA Pancreatic Endocrine Tumor Drug Sales Volume (K Pcs) by Application (2013-2025)
Figure EMEA Sales Market Share of Pancreatic Endocrine Tumor Drug by Application in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Research Center Examples
Table Key Downstream Customer in Research Center
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure EMEA Pancreatic Endocrine Tumor Drug Market Size (Million USD) by Region (2013-2025)
Figure Europe Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Pancreatic Endocrine Tumor Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Pancreatic Endocrine Tumor Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Pancreatic Endocrine Tumor Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Pancreatic Endocrine Tumor Drug Sales Volume and Growth Rate (2013-2025)
Figure EMEA Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Pancreatic Endocrine Tumor Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table EMEA Pancreatic Endocrine Tumor Drug Sales Volume (K Pcs) of Major Players (2013-2018)
Table EMEA Pancreatic Endocrine Tumor Drug Sales Share by Players (2013-2018)
Figure 2017 Pancreatic Endocrine Tumor Drug Sales Share by Players
Figure 2017 Pancreatic Endocrine Tumor Drug Sales Share by Players
Figure EMEA Pancreatic Endocrine Tumor Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Pancreatic Endocrine Tumor Drug Revenue (Million USD) by Players (2013-2018)
Table EMEA Pancreatic Endocrine Tumor Drug Revenue Share by Players (2013-2018)
Table 2017 EMEA Pancreatic Endocrine Tumor Drug Revenue Share by Players
Table 2017 EMEA Pancreatic Endocrine Tumor Drug Revenue Share by Players
Table EMEA Pancreatic Endocrine Tumor Drug Sale Price (USD/Pcs) by Players (2013-2018)
Table EMEA Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Market Share by Type (2013-2018)
Table EMEA Pancreatic Endocrine Tumor Drug Sales Share by Type (2013-2018)
Figure Sales Market Share of Pancreatic Endocrine Tumor Drug by Type (2013-2018)
Figure EMEA Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2013-2018)
Table EMEA Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Pancreatic Endocrine Tumor Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Pancreatic Endocrine Tumor Drug by Type in 2017
Table EMEA Pancreatic Endocrine Tumor Drug Sale Price (USD/Pcs) by Type (2013-2018)
Table EMEA Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Market Share by Application (2013-2018)
Table EMEA Pancreatic Endocrine Tumor Drug Sales Share by Application (2013-2018)
Figure Sales Market Share of Pancreatic Endocrine Tumor Drug by Application (2013-2018)
Figure EMEA Pancreatic Endocrine Tumor Drug Sales Market Share by Application in 2017
Table EMEA Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Market Share by Region (2013-2018)
Table EMEA Pancreatic Endocrine Tumor Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Pancreatic Endocrine Tumor Drug by Region (2013-2018)
Figure EMEA Pancreatic Endocrine Tumor Drug Sales Market Share in 2017
Table EMEA Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Pancreatic Endocrine Tumor Drug Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Pancreatic Endocrine Tumor Drug by Region (2013-2018)
Figure EMEA Pancreatic Endocrine Tumor Drug Revenue Market Share Regions in 2017
Table EMEA Pancreatic Endocrine Tumor Drug Sales Price (USD/Pcs) by Region (2013-2018)
Figure Europe Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Pancreatic Endocrine Tumor Drug Revenue and Growth Rate (2013-2018)
Table Europe Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Type (2013-2018)
Table Europe Pancreatic Endocrine Tumor Drug Market Share by Type (2013-2018)
Figure Europe Pancreatic Endocrine Tumor Drug Market Share by Type in 2017
Table Europe Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Application (2013-2018)
Table Europe Pancreatic Endocrine Tumor Drug Market Share by Application (2013-2018)
Figure Europe Pancreatic Endocrine Tumor Drug Market Share by Application in 2017
Table Europe Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Countries (2013-2018)
Table Europe Pancreatic Endocrine Tumor Drug Sales Market Share by Countries (2013-2018)
Figure Europe Pancreatic Endocrine Tumor Drug Sales Market Share by Countries (2013-2018)
Figure Europe Pancreatic Endocrine Tumor Drug Sales Market Share by Countries in 2017
Table Europe Pancreatic Endocrine Tumor Drug Revenue (Million USD) by Countries (2013-2018)
Table Europe Pancreatic Endocrine Tumor Drug Revenue Market Share by Countries (2013-2018)
Figure Europe Pancreatic Endocrine Tumor Drug Revenue Market Share by Countries (2013-2018)
Figure Europe Pancreatic Endocrine Tumor Drug Revenue Market Share by Countries in 2017
Figure Germany Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure France Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure UK Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Russia Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Italy Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Benelux Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Type (2013-2018)
Table Middle East Pancreatic Endocrine Tumor Drug Market Share by Type (2013-2018)
Figure Middle East Pancreatic Endocrine Tumor Drug Market Share by Type (2013-2018)
Table Middle East Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Applications (2013-2018)
Table Middle East Pancreatic Endocrine Tumor Drug Market Share by Applications (2013-2018)
Figure Middle East Pancreatic Endocrine Tumor Drug Sales Market Share by Application in 2017
Table Middle East Pancreatic Endocrine Tumor Drug Sales Volume (K Pcs) by Countries (2013-2018)
Table Middle East Pancreatic Endocrine Tumor Drug Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Pancreatic Endocrine Tumor Drug Sales Volume Market Share by Countries in 2017
Table Middle East Pancreatic Endocrine Tumor Drug Revenue (Million USD) by Countries (2013-2018)
Table Middle East Pancreatic Endocrine Tumor Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East Pancreatic Endocrine Tumor Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East Pancreatic Endocrine Tumor Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Israel Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure UAE Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Iran Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Type (2013-2018)
Table Africa Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2013-2018)
Figure Africa Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2013-2018)
Figure Africa Pancreatic Endocrine Tumor Drug Sales Market Share by Type in 2017
Table Africa Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Application (2013-2018)
Table Africa Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2013-2018)
Figure Africa Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2013-2018)
Table Africa Pancreatic Endocrine Tumor Drug Sales Volume (K Pcs) by Countries (2013-2018)
Table Africa Pancreatic Endocrine Tumor Drug Sales Market Share by Countries (2013-2018)
Figure Africa Pancreatic Endocrine Tumor Drug Sales Market Share by Countries (2013-2018)
Figure Africa Pancreatic Endocrine Tumor Drug Sales Market Share by Countries in 2017
Table Africa Pancreatic Endocrine Tumor Drug Revenue (Million USD) by Countries (2013-2018)
Table Africa Pancreatic Endocrine Tumor Drug Revenue Market Share by Countries (2013-2018)
Figure Africa Pancreatic Endocrine Tumor Drug Revenue Market Share by Countries (2013-2018)
Figure Africa Pancreatic Endocrine Tumor Drug Revenue Market Share by Countries in 2017
Figure South Africa Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Nigeria Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Egypt Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Algeria Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Table Ipsen S.A. Pancreatic Endocrine Tumor Drug Basic Information List
Table Ipsen S.A. Pancreatic Endocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Ipsen S.A. Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Ipsen S.A. Pancreatic Endocrine Tumor Drug Sales Market Share in EMEA (2013-2018)
Figure Ipsen S.A. Pancreatic Endocrine Tumor Drug Revenue Market Share in EMEA (2013-2018)
Table Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Basic Information List
Table Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Sales Market Share in EMEA (2013-2018)
Figure Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Revenue Market Share in EMEA (2013-2018)
Table MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Basic Information List
Table MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Sales Market Share in EMEA (2013-2018)
Figure MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Revenue Market Share in EMEA (2013-2018)
Table Novartis AG Pancreatic Endocrine Tumor Drug Basic Information List
Table Novartis AG Pancreatic Endocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis AG Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Novartis AG Pancreatic Endocrine Tumor Drug Sales Market Share in EMEA (2013-2018)
Figure Novartis AG Pancreatic Endocrine Tumor Drug Revenue Market Share in EMEA (2013-2018)
Table OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Basic Information List
Table OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Sales Market Share in EMEA (2013-2018)
Figure OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pancreatic Endocrine Tumor Drug
Figure Manufacturing Process Analysis of Pancreatic Endocrine Tumor Drug
Figure Pancreatic Endocrine Tumor Drug Industrial Chain Analysis
Table Raw Materials Sources of Pancreatic Endocrine Tumor Drug Major Manufacturers in 2017
Table Major Buyers of Pancreatic Endocrine Tumor Drug
Table Distributors/Traders List
Figure EMEA Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure EMEA Pancreatic Endocrine Tumor Drug Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Pancreatic Endocrine Tumor Drug Price (USD/Pcs) and Trend Forecast (2018-2025)
Table EMEA Pancreatic Endocrine Tumor Drug Sales (K Pcs) Forecast by Region (2018-2025)
Figure EMEA Pancreatic Endocrine Tumor Drug Sales Market Share Forecast by Region (2018-2025)
Table EMEA Pancreatic Endocrine Tumor Drug Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Pancreatic Endocrine Tumor Drug Revenue Market Share Forecast by Region (2018-2025)
Table Europe Pancreatic Endocrine Tumor Drug Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Europe Pancreatic Endocrine Tumor Drug Sales Market Share Forecast by Countries (2018-2025)
Table Europe Pancreatic Endocrine Tumor Drug Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Pancreatic Endocrine Tumor Drug Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Pancreatic Endocrine Tumor Drug Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Middle East Pancreatic Endocrine Tumor Drug Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Pancreatic Endocrine Tumor Drug Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Pancreatic Endocrine Tumor Drug Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Pancreatic Endocrine Tumor Drug Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Africa Pancreatic Endocrine Tumor Drug Sales Market Share Forecast by Countries (2018-2025)
Table Africa Pancreatic Endocrine Tumor Drug Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Pancreatic Endocrine Tumor Drug Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Pancreatic Endocrine Tumor Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure EMEA Pancreatic Endocrine Tumor Drug Sales Market Share Forecast by Type (2018-2025)
Table EMEA Pancreatic Endocrine Tumor Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure EMEA Pancreatic Endocrine Tumor Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources